Customer testimonials
Real-world feedback from researchers, biotech teams, CROs, pharmaceutical organisations and distribution partners using Atelerix products to preserve cells, tissues, organoids and biosamples without conventional cryopreservation.
A note on these testimonials
Our customers work in highly competitive scientific and commercial environments. Some are happy to be named publicly; others, particularly larger pharmaceutical and life sciences organisations, prefer to remain anonymised. Where a company name is not shown, we have included the contributor’s role and organisation type for context. Atelerix retains full knowledge of each contributor and can facilitate direct reference conversations where appropriate.
1.Cell Therapy & Clinical Translation
Feedback from organisations using Atelerix technology to support fragile cell preservation, clinical translation and fresh cell-based therapy logistics.
“The product improved cell preservation and viability over prolonged transit durations at room temperature, enabling equitable distribution of an ocular cell-based therapy to tertiary sites in our network. This has recently been validated in a Phase 0/I clinical trial, which has successfully reached its 2-year follow-up”
Syan Basu, Dir. of Research
LV Prasad Eye Institute
“I was amazed that these fragile cells bounced back after a whole weekend at room temperature. This is potentially transformative for cell therapy delivery.”
James Foster, Scientific Director
Lions World Vision Institute
“We are incredibly proud of our ability to ship in vitro liver models from the UK to the US without freezing or cryopreserving by partnering with Atelerix Ltd. This represents a watershed moment, since we can now ship our iPSC-derived hepatocytes fresh to customers in assay-ready plates for screening and analysis, enhancing the quality of functional assays. This saves research time, as cells do not need to be thawed, and avoids the need for cold chain logistics.”
Celine Gomez, Dir. Operations
DefiniGEN (Now Pixl Bio)
2. Drug Discovery & Pharmaceutical Development
Customer experiences from assay development, pharmaceutical research and biopharma teams using Atelerix to simplify cell handling, preserve viability and reduce reliance on freezing.
“The product is very easy to use - it certainly felt faster than preparing cells to freeze. Cells were 98% viable after 3 days and 89% viable after 6 days and cell grew very well, becoming fully confluent over the weekend”
Hannah Spencer, Assay Development Scientist
LabCorp
“The cells achieved greater than 80% viability and looked healthier under the microscope. CytoStor is nice in that the cells are suspended in a matrix, preventing clumping at the bottom of the tube. I am keen to use CytoStor for cell shipments from
Europe to our research site in Oxford.”
Snr. Research Scientist - Innovative US-Based Biopharmaceutical Company
“We stored HeLa cells for 5 days at both room temperature and at 2-8°C and achieved 96 and 97% viability, respectively. Cells were returned to culture and exhibited normal growth. We will be looking to use Atelerix’s products for more sensitive cells and spheroids.”
Snr. Scientist - Leading Multinational Biopharmaceutical Company
"CytoStor was working perfectly for our needs. It really saved us a lot of headaches and we were very pleased with its performance"
Associate Scientist - North American Drug Development Organisation
"You guys and your product are great"
Snr. Associate Scientist - Global Tier 1 Pharmaceutical Company
“Neutrophils had great viability after the preservation with Cytostor. These numbers are truly impressive and quite surprising to me"
Senior Scientist - AI-Driven Cell Analysis Technology Company
3. Advanced In Vitro Models
Testimonials from teams working with organoids, spheroids, tissues, transwells and complex models where preservation quality directly affects downstream performance.
“In the past months, we have thoroughly tested your product, and we are really satisfied with its performance. We have, namely, tested with two of our models and, particularly for one of the models, your hydrogel seems to work beyond expectations”
Dario Fassini, CSO & Head of Preclinical Models Development - Cherry Biotech
“We've always struggled to ship Labskin very long distances as it needs feeding within 96 hours, ideally 72 hours. If it gets stuck in transit, usually customs clearance, it's detrimental to the quality of our model. As you can see from the data, the Atelerix product will allow us to go beyond that 96-hour window and maintain the structure of our skin model. Happy days!”
Nicola Kingswell, Scientific Director - LabSkin
“Our ImmuPHAGE™ alveolar-like macrophages are crucial for human-relevant lung and immune research, but shipping these cells has been a challenge. We used their innovative WellReady™ technology to transport ImmuPHAGE™. This collaboration
testifies to the robustness of our in vitro models, boosting our confidence in successfully shipping these cells and unlocking new opportunities with our customers.”
Victoria Hutter, CSO - ImmueOne
“We're happy with how WellReady performed on our transwell cultures. Our cells behaved as expected after room temperature incubation.”
Research Scientist II - Specialist 3D Tissue Model CRO
“Your product worked well for preserving our tissues. I would love to scale-up the use of your product to a 96-well plate format”
Scientist - Gene Engineering Biotechnology Company
“We are very happy with the results of the testing. We did not see a big increase in the amount of cell death upon storage in Atelerix gel for 7 days at RT. We also like the fact that the gel encapsulates the organoid, helping to protect them from any physical damage during shipping.”
Senior Research Associate - Leading Cell Biology Solutions Provider
4. SUPPLY CHAIN & COMMERCIAL DISTRIBUTION
Real-world feedback from partners using Atelerix to make biosample movement simpler, more resilient, more sustainable and less dependent on costly cold-chain logistics.
“This partnership represents a major step forward in how science moves. For too long, researchers and developers have had to rely on costly, energy-intensive cold chains that often limit access and add complexity. By integrating Atelerix’s technology into
our network, we are delivering smarter, more sustainable solutions that help researchers everywhere get their discoveries where they’re needed most.ˮ
Len Lazarus, CEO - Rodon Global
“Atelerix’s gel preserved our valuable cells during an unintended 10 - 12 day transit from UK to India, far surpassing the expected viability in such harsh conditions. This breakthrough slashed our shipping costs from ~$2,500 to ~$200. We are rolling Atelerix products out across all our biosample shipments.”
Keith Woodley, Snr. Scientist - O2H
Explore an ambient biosample workflow with Atelerix
See how ambient transport could simplify your sample handling, reduce cold-chain dependency and support more sustainable logistics workflows.
Book a workflow discussion
For research groups, biotechs and therapy developers exploring ambient transport.
Explore the science
Learn how Atelerix preservation technology supports ambient transport and handling.
